Fayaj L Pathan*

Associate Professor, MIT College of Food Technology, MIT Art, Design and Technology University, Pune, India

*Corresponding Author: Fayaj L Pathan, Associate Professor, MIT College of Food Technology, MIT Art, Design and Technology University, Pune, India.

Received: December 21, 2023; Published: January 01, 2024

Abstract

Obesity and metabolic syndrome affects to the liver of about quarter of global population causing Nonalcoholic Fatty Liver Disease (NAFLD). It became the most common form of chronic liver disease in children and adolescents. NAFLD is caused due to systemic metabolic dysfunction and it simultaneously increase the risk of cardiovascular disease and diabetes [1].

References

1. Eslam M and George J. “Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology”. Nature Reviews Gastroenterology and Hepatology (2019).
2. Sanyal AJ. “Past, present and future perspectives in nonalcoholic fatty liver disease”. Nature Reviews Gastroenterology and Hepatology 16 (2019): 377-386.
3. Sutti S and Albano E. “Adaptive immunity: an emerging player in the progression of NAFLD”. Nature Reviews Gastroenterology and Hepatology (2019).
4. Nobili V., et al. “NAFLD in children: new genes, new diagnostic modalities and new drugs”. Nature Reviews Gastroenterology and Hepatology 16 (2019): 517-530.

Citation

Citation: Fayaj L Pathan. “Nonalcoholic Fatty Liver Disease (NAFLD) A Chronic Liver Disease".Acta Scientific Nutritional Health 8.2 (2024): 02.

Copyright

Copyright: © 2024 Fayaj L Pathan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.